OptiTROP-Lung04
What it tests: Final overall survival of sacituzumab tirumotecan vs platinum chemo in EGFR-mutated NSCLC after EGFR-TKI progression

Listen to Oncology Here & Now
What it tests: Final overall survival of sacituzumab tirumotecan vs platinum chemo in EGFR-mutated NSCLC after EGFR-TKI progression
HARMONi-6and 3 moreDr. Gil MorganDr. Gil Morgan. Daily round-up. ESMO 2025. Day 3.
The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.